These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2004-000242-20 A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy 2018-12-31 bad-data
Ongoing 2004-000405-22 TE23: Randomised Phase II trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP chemotherapy in poor prognosis male germ cell tumours. not-yet-due
Not reported 2004-002951-16 COIN A three-arm randomised controlled trial comparing either COntinous chemotherapy plus cetuximab or INtermittent chemotherapy with standard coninuous palliative combination chemotherapy with oxalip... 2012-08-01 due-trials
Ongoing, reported early 2005-002114-38 Ensayo randomizado para determinar el tratamiento óptimo de pacientes con infección por VIH en quienes la terapia con TARGA de primera y segunda línea ha fracasado not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-003929-22 Estudio aleatorizado del “Gynaecologic Cancer InterGroup”, de dos grupos, multicéntrico para añadir bevacizumab a la quimioterapia estándar (carboplatino y paclitaxel) en pacientes que sufren cáncer e... 2013-06-28 bad-data
Ongoing 2005-004527-19 Joint pain personalised treatment assessment to investigate the acceptability of modified release oxycontin for managing chronic pain in patients with osteoarthritis of the hip not-yet-due
Ongoing 2006-000205-34 Radiotherapy and Androgen Deprivation in Combination After Local Surgery. A randomised controlled trial for patients with prostate cancer. not-yet-due
Ongoing 2006-000811-12 A Randomised Phase II/III trial of peri-operative Chemotherapy with or without Bevacizumab in Operable Oesophagogastric Adenocarcinoma and A Feasibility Study Evaluating Lapatinib in HER-2 Positive Oe... not-yet-due
Ongoing, reported early 2006-003049-17 A two-arm randomised trial of intermittent chemotherapy plus continuous cetuximab and of intermittent chemotherapy plus intermittent cetuximab in first line treatment of metastatic colorectal cancer not-yet-due
Ongoing 2006-006079-19 A Phase III Randomised Double-blind Study Comparing Sorafenib With Placebo In Patients With Resected Primary Renal Cell Carcinoma at High or Intermediate Risk of Relapse not-yet-due
Ongoing 2007-001346-41 A double-blind, placebo-controlled, three arm randomised multi-centre Gynaecologic Cancer InterGroup trial of AZD2171, in combination with platinum-based chemotherapy and as a single agent maintenance... not-yet-due
Ongoing, reported early 2007-004429-45 A randomised trial to determine the impact of timing of surgery and chemotherapy in newly diagnosed patients with advanced epithelial ovarian, primary peritoneal or fallopian tube carcinoma not-yet-due
Not reported 2007-005057-36 Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) 2011-02-28 due-trials
Ongoing 2007-006448-23 A randomised controlled trial of a strategy of switching to boosted protease inhibitor monotherapy versus continuing combination antiretroviral therapy for the long-term management of HIV-1 infected p... not-yet-due
Not reported 2008-008323-15 FOCUS 3 A study to determine the feasibility of molecular selection of therapy using KRAS, BRAF and topo-1 in patients with metastatic or locally advanced colorectal cancer. 2014-08-28 due-trials
Ongoing, reported early 2009-011264-11 A randomized, double blind, placebo controlled, phase II, multi-centre pilot study to investigate the effects of vitamin D2 or D3 supplementation on metabolic parameters in people at risk of type 2 di... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-012947-40 BREATHER (PENTA 16): Short-Cycle Therapy (SCT) (5 days on/2 days off) in young people with chronic HIV 2016-09-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-013648-35 A Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-dailyversus once-daily Iopinavir/ritonavir tablets dosed by weight as part of combination antiretroviral the... 2014-06-06 bad-data
Ongoing 2010-022209-16 ICON8: An international phase III randomised trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy, following immediate primary surgery or as part of delayed primary s... not-yet-due
Ongoing, reported early 2012-000344-10 Adjunctive Rifampicin to Reduce Early mortality from Staphylococcus aureus bacteraemia: a randomised controlled trial not-yet-due
Ongoing, reported early 2012-002373-56 PRe-exposure Option for reducing HIV in the UK: an open-label randomisation to immediate or Deferred daily Truvada for HIV negative gay men not-yet-due
Ongoing 2012-005111-12 FOCUS4 – Molecular selection of therapy in colorectal cancer: a molecularly stratified randomised controlled trial programme not-yet-due